Rolf H. Henel, Director at SCICLONE PHARMACEUTICALS INC (SCLN), sold 9,400 shares at $2.15 ($20K) on 2007-12-31, disclosed to the SEC on 2008-01-02.
Open-market sale of $20k SCLN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.03 | 3,568 | $7K | 37.1% |
| 2 | $2.04 | 500 | $1K | 5.2% |
| 3 | $2.04 | 1,600 | $3K | 16.7% |
| 4 | $2.12 | 1,398 | $3K | 15.2% |
| 5 | $2.15 | 2,334 | $5K | 25.7% |
| Total | $2.08 avg | 9,400 |
| $20K |
| 100% |
| Filing → |